Table 1.

The progression of myopia during the 3 years prior to the commencement of treatment (left to right), the refractive error and VA at the beginning of treatment and the progression of myopia and VA wearing MiSight lenses at the end of 1 year of treatment

Age	Gender	Eye	Average K, mm	P-D	P-N	Myopia progression (Spherical equivalent) 3 years prior to therapy, D			Rx at commencement of treatment, D	VA beginning of therapy	0.01% stropine + MiSight 12 months	VA with lenses
10	Female	R	7.65	Ortho	IEP	1.25	0.75	0.75	−4.00 to −0.50 × 20	6/6	Pl	6/6-
		L	7.60			1.25	1	0.75	−3.75 to −0.50 × 180	6/6	0.25	6/6-
8	Female	R	7.80	2XP	Ortho	1.25	1	1.00	−3.50	6/5	0.50	6/6
		L	7.75			1.25	1	0.75	−3.75	6/5	0.25	6/6
9.5	Female	R	7.70	Ortho	3EP	0.75	0.50	0.75	−5.00 to −0.75 × 160	6/6	0.25	6/6-
		L	7.75			1	0.75	0.75	−4.75 to −0.75 × 180	6/6	Pl	6/6-

K, keratometry; P-D, phoria distance; P-N, phoria near; D, diopter; VA, visual acuity.